Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study
Attention Deficit Hyperactivity Disorder
About this trial
This is an interventional treatment trial for Attention Deficit Hyperactivity Disorder focused on measuring Children, ADHD, rTMS, Safety
Eligibility Criteria
Inclusion Criteria:
- Ages eligible for Study: 7years to 12 years
- Genders Eligible for Study: Both
Exclusion Criteria:
- History of convulsions
- Co-morbidity with other psychiatric or neurologic disease
Sites / Locations
- International Center for Neurological RestorationRecruiting
Arms of the Study
Arm 1
Experimental
Transcranial magnetic stimulation
There are evidences that rTMS has a modulating effect in cortical and subcortical neural networks, reinforcing or depressing synaptic activity by mean of long term potentiation or depression like mechanism. Depression is the most study neuropsychiatric condition in which rTMS is useful as a therapeutic option; but in other diseases such as ADHD there are many pathophysiological elements that make it very likely that rTMS could be useful for symptomatic treatment modulating activity in prefrontal and basal ganglia neuronal networks.